Efficacy and Safety of High Dose Intravenous Iron for Treatment Iron Deficiency Anemia in Gynecologic Malignancy Disease: Retrospective Cohort Study

Recruiting

• Conditions: Petient who has Iron deficiency anemia in gynecologic malignancy disease; Iron deficiency anemia, iv iron, gynecologic malignancy disease

• Registration Number: TCTR20230815001
• Lead Sponsor: Faculty of Medicine, KhonKaen university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-08-15
• Study Completion: 2024-04-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 108

Inclusion Criteria

1. Patient who diagnosed with gynecologic-oncology disease recieving chemotherapy between 01/01/2020-31/05/2023 in Srinagarind hospital
2. Age more than 18 years old
3. Hb < 12 g/dL
4. met criteria of inrondeficiency anemia

Exclusion Criteria

1. Anemia due to bone marrow disease
2. Ferritin > 800 ng/ml
3. Transferring saturation equal or greater than 50%
4. Incomplete information

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood transfusion rate at the time of complete chemotherapy course Number of blood transfusion per chemotherapy course

Secondary Outcome Measures

Name	Time	Method
maintaing hemoglobin within 0.5 mg/dL of basline at the time of complete chemotherapy course Hemoglobin level